68 Ga-NODAGA-E[c(RGDγK)]2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68 Ga-NODAGA-E[c(RGDγK)]2, covering 2020-07-14 to 2020-07-14. Get the full timeline:
Most recent: Clinical Trial Update: 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis [Phase 2]